The well-characterized REVERBα agonist GSK4112 (36) repressed TGFβ-induced expression of αSMA (ACTA2) and collagen-1 (COL1A1) in primary human lung fibroblasts from patients with pulmonary fibrosis (Fig. 5C). This evidence concerns the gene TGFB1 and pulmonary fibrosis.